Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients

BACKGROUND: Direct-acting antiviral (DAA) agents target HCV proteins; some of these have already been approved for the treatment of HCV infection, while others are in development. However, selection of DAA-resistant viral variants may hamper treatment. The aim of this study was to illustrate potenti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Paolucci, Stefania, Fiorina, Loretta, Mariani, Bianca, Gulminetti, Roberto, Novati, Stefano, Barbarini, Giorgio, Bruno, Raffaele, Baldanti, Fausto
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878512/
https://ncbi.nlm.nih.gov/pubmed/24341898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-10-355
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia